Cardinal will beef up its direct-to-home distribution channels
Cardinal is paying $2.07 billion for the privately held company, which it says had 2012 sales of about $1 billion, including the recently acquired Invacare Supply Group. AssuraMed operates through two separate businesses, Independence Medical and Edgepark Medical Supplies.
Besides building on its massive healthcare distribution network already in place, Cardinal says that “AssuraMed’s expertise in products for specific disease categories and small parcel logistics will significantly enhance Cardinal Health’s ability to service customers across the broad ambulatory care channel, including care sites such as physician offices and in support of home health agencies.” Eventually, says the company, it will supply the home healthcare channel with product lines including ostomy, diabetes, insulin therapy, urological, wound care and incontinence; and to use this acquisition as a platform to begin offering a variety of its current house-brand product offerings in the direct-to-home channel.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.